90 Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies

Authors:

Abstract
No abstract available
Keywords

This publication has 24 references indexed in Scilit: